Health Catalyst (HCAT) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by General Counsel, conducted as an audio webcast in accordance with bylaws and Delaware law.

• Notice and proxy statement mailed to stockholders of record as of May 22, 2026.

• Voting procedures and Q&A process explained, with digital access to materials and online voting.

• Directors, officers, and independent auditor introduced; quorum confirmed with 54,417,854 shares represented.

Board and executive committee updates

• Two nominees, Justin Spencer and Matt Arens, presented for election as Class I directors to serve until the 2029 annual meeting.

• No stockholder nominations for directors received; nominations declared closed.

Corporate governance

• Proposal to ratify Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026, submitted for shareholder vote as a governance measure.

• Advisory, non-binding vote on executive compensation presented for shareholder approval.

• Proposal to phase out classified board structure and move to annual director elections for those elected on or after 2029 presented, requiring 66.67% approval.